Montelukast Prescribing at MERROW PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
318
Total Quantity
15.5K
NHS Cost
£762
vs National Avg
-53.6%
MERROW PARK SURGERY prescribed 318 items of Montelukast over the last 12 months at a cost of £762 to the NHS. This is 53.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
31
Jul 2026
20
Jul 2026
27
Jul 2026
24
Jul 2026
26
Jul 2026
35
Jul 2026
19
Jul 2026
34
Jul 2026
28
Jul 2026
23
Jul 2026
24
Jul 2026
27
Prescribing Details
| Total Items | 318 |
|---|---|
| Total Quantity | 15,512 |
| Total NHS Cost | £762 |
| Presentations | 4 different forms |
| vs National Average | -53.6% |
Montelukast Prescribing Comparison
| This practice | 318 items |
|---|---|
| National average per practice | 685 items |
| Difference | -53.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.